Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Payments for Colon Ca Treatments Vary Widely

J Surg Res; 2017 Dec; Gani, Cerullo, Canner, et al

Payments for colon cancer treatments vary extensively, researchers concluded after conducting a study involving >18,000 individuals. Patients underwent a colectomy for colon cancer between 2010 and 2014. Investigators calculated and compared risk-adjusted payments. Among the results:

  • The median risk-adjusted payment for surgery was ~$26,400.
  • Payments ranged between ~ $19,800 among patients in the lowest quartile of payments to ~$33,800 for patients in the highest quartile.
  • The median risk-adjusted payment for chemotherapy was ~$70,100.
  • Chemotherapy payments were 40% higher in patients in the highest vs lowest quartile.
  • Patients in the highest two quartiles comprised 59% of all payments.
  • Patients who were younger, had increasing comorbidities, or underwent an open operation tended to have higher overall payments.

Citation:

Gani F, Cerullo M, Canner J, et al. Defining payments associated with the treatment of colorectal cancer. J Surg Res. 2017;220:284-292. doi:10.1016/j.jss.2017.07.021.